Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
customary, driven, enzyme, Keytruda, letter, modification, Odomzo, Opdivo, qui, Summary, Tecentriq, Tesaro, tied, unused, waived, waiver
Removed:
exploratory, KeytrudaTM, offsetting, OpdivoTM, operational, orqui, pidilizumab, Shanghai, twelve, unamortized
Filing tables
Filing exhibits
Related press release
CRIS similar filings
Filing view
External links